There could be an upside to incorporating AI for the FDA. Using AI to assist in final drug reviews would "represent a chance ...

OpenAI has reportedly met with officials from the U.S. Food and Drug Administration (FDA) to discuss the use of artificial ...

OpenAI has reportedly met with officials from the Food and Drug Administration to discuss how AI could speed up drug ...

Industry officials told WSJ the disruptions are leading to longer drug development timelines and increased uncertainty for both companies and investors. One biotech company developing a treatment ...

The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible ...

Supposedly, the AI tool will speed up the FDA's drug review process by reducing the time its scientists have to spend doing ...

OpenAI is in talks with the US FDA about using AI, potentially via a project called cderGPT, to assist in drug evaluations, ...